Skip to content
🧬 New: 3 PDRN clinical studies added this weekπŸ”¬ 120+ PDRN products compared β€” find your matchπŸ“© Free weekly PDRN research digest β€” subscribe below
PDRN Care
ProtocolIntermediate

PDRN Scalp Rejuvenation Treatment Protocol

A clinical protocol for PDRN-based scalp treatment to promote hair health and growth, covering mesotherapy injection technique, topical approaches, treatment scheduling, and patient management.

Dr. Min-Ji Park

Dr. Min-Ji Park

MD, Board-Certified Dermatologist

7 minApril 11, 2026

Overview

This protocol describes a comprehensive PDRN-based scalp treatment approach for promoting hair health, stimulating follicle activity, and improving hair density [1][4]. The protocol integrates two complementary delivery methods: intradermal mesotherapy for direct follicular targeting and topical application for ongoing scalp conditioning [1][4]. PDRN's mechanism of action via adenosine A2A receptor activation makes it particularly well-suited for scalp rejuvenation, as it promotes dermal papilla cell proliferation, upregulates VEGF-driven perifollicular angiogenesis, and provides nucleotide building blocks for hair matrix cell division [2][3][5].

Rationale

Hair follicle miniaturization in androgenetic alopecia and other thinning conditions is driven by reduced blood supply, impaired growth factor signaling, and shortened anagen (growth) phase [1][4]. PDRN addresses these factors through several mechanisms [2][3]:

  • Dermal papilla stimulation β€” PDRN activates A2A receptors on dermal papilla cells, promoting proliferation and growth factor secretion essential for follicle cycling [2][3]
  • Perifollicular angiogenesis β€” PDRN upregulates VEGF expression, enhancing the blood supply to the hair follicle, which is critical for sustaining the anagen phase [5]
  • Anti-inflammatory action β€” PDRN suppresses perifollicular micro-inflammation, a contributor to progressive follicle miniaturization [2]
  • Nucleotide salvage β€” PDRN provides deoxyribonucleotide building blocks for the rapidly proliferating hair matrix cells during active growth [3]

Patient Selection

Indications

  • Androgenetic alopecia (Ludwig grade I-II in women, Hamilton-Norwood grade II-IV in men) [1][4]
  • Diffuse thinning and telogen effluvium (post-acute phase) [1]
  • Early-stage alopecia with miniaturized but viable follicles [4]
  • Post-partum hair thinning (after stabilization) [1]
  • Adjunctive treatment alongside minoxidil, finasteride, or low-level laser therapy [4]
  • Scalp preparation prior to hair transplant surgery [4]

Contraindications

  • Cicatricial (scarring) alopecia β€” follicles are permanently destroyed
  • Alopecia areata in active phase β€” consider immunotherapy first
  • Known hypersensitivity to fish-derived products
  • Active scalp infection (folliculitis, tinea capitis) β€” treat first
  • Pregnancy or breastfeeding
  • Anticoagulant therapy (relative β€” assess bleeding risk)
  • Unrealistic expectations β€” PDRN cannot regrow hair from fully miniaturized or absent follicles

Pre-Treatment Preparation

  1. Consultation β€” Perform a comprehensive hair and scalp assessment: medical history, family history of alopecia, hormonal evaluation (if indicated), pull test, and baseline trichoscopic evaluation with phototrichogram [1][4]. Set realistic expectations based on follicle status.
  2. Scalp preparation (1-2 weeks prior) β€” Optimize scalp health: treat any dandruff or seborrheic dermatitis, discontinue harsh styling products, and ensure a clean, healthy scalp environment [4].
  3. Baseline documentation β€” Capture standardized photographs (vertex, frontal, temporal, and occipital views) and phototrichogram at a fixed reference point [1][4].
  4. Day of treatment β€” Shampoo the scalp with a gentle, residue-free cleanser. Towel dry. Do not apply any styling products, oils, or leave-in treatments.

Equipment

  • Injectable PDRN solution (5.625 mg/3 mL or equivalent concentration)
  • 30G or 32G mesotherapy needles (4 mm length)
  • Mesotherapy injection gun or manual syringe technique
  • Antiseptic solution (chlorhexidine 0.05%)
  • Topical anesthetic cream (lidocaine 2.5%/prilocaine 2.5%) β€” optional
  • PDRN scalp serum or ampoule (topical-grade for home care)
  • Derma roller 0.25-0.5 mm (optional, for enhanced topical absorption)

Treatment Technique

Step 1: Scalp preparation

Cleanse the scalp with antiseptic solution [4]. Part the hair systematically to expose the treatment area. If using topical anesthesia, apply under occlusion for 20 minutes, then remove and re-cleanse.

Step 2: PDRN mesotherapy injection

Perform intradermal injections across the affected scalp areas using a standardized grid pattern [1][4]:

ParameterSpecification
Needle gauge30G or 32G
Injection depth3-4 mm (intradermal to upper subcutaneous)
Volume per point0.05 mL
Spacing1 cm apart in grid pattern
Total volume3-5 mL per session (depending on area)
TechniqueNappage β€” rapid, superficial injections at 30-45 degree angle

Technique notes:

  • Begin at the frontal hairline or vertex center and work systematically outward [4]
  • Part the hair at each injection row for accurate placement [4]
  • Maintain consistent depth and volume across all injection points
  • Gentle pressure with gauze after each row to control bleeding
  • Cover the entire affected area plus a 1-2 cm margin into unaffected scalp [4]

Step 3: Post-injection scalp massage

After completing injections, perform a gentle 2-3 minute scalp massage to distribute PDRN solution evenly and improve absorption [4]. Use light circular motions with fingertips β€” avoid vigorous rubbing.

Step 4: Topical PDRN application (home care)

Prescribe a PDRN scalp serum for daily home use [3]. Instruct the patient to:

  • Apply 1-2 mL of PDRN serum to the affected areas nightly
  • Part the hair and apply directly to the scalp β€” not the hair shafts
  • Massage gently for 1-2 minutes
  • Leave on overnight; wash out in the morning if preferred
  • Optionally use a 0.25 mm derma roller once weekly before serum application to enhance absorption [6]

Treatment Schedule

PhaseSessionsIntervalPurpose
Induction8 sessionsEvery 2 weeksActivate dormant follicles and establish angiogenesis [1][4]
Consolidation4 sessionsEvery 4 weeksSustain follicle activation and collagen remodeling [1][4]
MaintenanceOngoingEvery 6-8 weeksPreserve gains and prevent regression [1]

Daily topical PDRN serum should be used continuously throughout all phases [3]. The full induction course (8 sessions) is critical for optimal results β€” premature discontinuation may result in incomplete response [4].

Post-Treatment Care

Immediate (first 24 hours)

  • Do not wash the scalp for at least 12 hours after mesotherapy to allow maximum PDRN absorption [4]
  • Mild erythema, pinpoint bleeding, and tenderness at injection sites are expected and resolve within 24 hours [1][4]
  • Avoid vigorous exercise, saunas, swimming pools, and hats that press tightly on the scalp
  • Apply PDRN scalp serum in the evening if more than 12 hours have passed

Days 2-7

  • Resume normal gentle shampooing after 24 hours [4]
  • Continue daily PDRN scalp serum application [3]
  • Avoid harsh chemical treatments (coloring, perming, straightening) for 1 week [4]
  • Avoid direct prolonged sun exposure to the scalp β€” wear a loose hat if needed

Week 2 onward

  • Continue topical PDRN serum daily [3]
  • Resume all normal hair care routines
  • If using minoxidil, resume 48 hours after mesotherapy session [4]
  • Monitor for early signs of improvement (reduced shedding, new vellus hairs) at the 8-week mark [1][4]

Expected Outcomes

Results are gradual and require commitment to the full treatment course [1][4]:

  • Weeks 2-4 β€” Reduced hair shedding reported by most patients; initial scalp condition improvement [1]
  • Weeks 8-12 β€” Trichoscopic evidence of new vellus hair growth, increased anagen ratio, and early density improvement [1][4]
  • Weeks 16-24 β€” Measurable increase in hair density and shaft diameter; visible cosmetic improvement noted by patient and clinician [1][4]
  • Months 6-12 β€” Peak results with maximum density gains; ongoing maintenance required to sustain improvements [1][4]

Clinical studies suggest that PDRN scalp mesotherapy produces an average increase of 15-25 hairs/cmΒ² and 10-15% increase in shaft diameter over a 24-week treatment course, with best results in patients with early-stage alopecia and viable miniaturized follicles [1][4].

Reviewed by Dr. Sarah Chen, PhD, Molecular Biology

References

  1. [1]
    Squadrito F, Bitto A, Irrera N, Pizzino G, Pallio G, Minutoli L, Altavilla D. Pharmacological Activity and Clinical Use of PDRN. Current Pharmaceutical Design. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
  2. [2]
    Colangelo MT, Galli C, Gentile P. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Current Pharmaceutical Design. 2020;26(17):2049-2056.
  3. [3]
    Kim TH, Kim JH, Lee SH, Park ES. Biostimulatory effects of polydeoxyribonucleotide for facial skin rejuvenation. Journal of Cosmetic Dermatology. 2019;18(6):1767-1773. doi:10.1111/jocd.12958
  4. [4]
    Galeano M, Bitto A, Altavilla D, Minutoli L, Polito F, Calo M, Lo Cascio P, Stagno d'Alcontres F, Squadrito F. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair and Regeneration. 2008;16(2):208-217. doi:10.1111/j.1524-475X.2008.00361.x
  5. [5]
    Dhurat R, Sukesh MS. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. Journal of Cutaneous and Aesthetic Surgery. 2014;7(4):189-197. doi:10.4103/0974-2077.150734
  6. [6]
    Lee SH, Zheng Z, Kang JS, Kim DY, Oh SH, Cho SB. Clinical efficacy evaluation of micro-droplet injection of polynucleotide for skin rejuvenation. Journal of Korean Medical Science. 2018;33(44):e282. doi:10.3346/jkms.2018.33.e282
ShareTwitterLinkedIn

Search

Search across products, blog posts, wiki articles, and more.